Group A streptococcal strains isolated from rheumatic fever patients were cultivated in the presence of bovine heart valves in a medium devoid of components from animal origin. Other group A streptococci and various bacteria were used as controls. The supernatant of these cultures was extracted and analyzed chemically and immunologically. The extracts prepared from cultures of two "rheumatogenic" strains in the presence of bovine heart valves showed fraction(s) containing proteins, oses (neutral and amined), and uronic and sialic acids. This fraction(s) was immunologically active with both anti-group A streptococcus and antisoluble connective glycoprotein antisera, with a partial identity reaction. Experiments with a diffusion chamber and attempts to precipitate a postulated enzyme from the culture of these strains by ammonium sulfate suggest that this action is due to an extracellular product of the bacteria. The meaning of these data in the physiopathology of rheumatic cardiac lesions is briefly discussed.
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The process whereby a group A streptococcal infection of the upper respiratory tract can lead to a cardiac lesion during a rheumatic fever attack has been much debated, and is still an interesting challenge to physiopathology. Schematically, the hypotheses made to explain these lesions fall into three groups: (i) local action of streptococcal toxin(s) or enzyme(s); (ii) infectious foci due either to bacteria or to modified forms of bacteria, or (iii) immune mechanism (5) . During the last few years, the third hypothesis has been favored in several studies, but the real nature of the streptococcal antigen(s) involved in the setting in motion of a possible autoimmune reaction has not been firmly established (19) . One of us has described an immunological cross-reaction between the polysaccharide (C antigen) of the group A streptococcus and certain structural glycoproteins of the connective tissue of heart valves (9) . The hypothesis that group A streptococcal polysaccharide plays a role in the pathogenesis of rheumatic cardiac lesions received further support when it was shown that sera of patients with rheumatic heart lesions still contain a large amount of antibodies to this antigen, even a long time after the acute crisis (3). However, since the crossreactive glycoprotein belongs most probably to the deep structures of the connective tissue of the heart, it had to be assumed that, during the course of the streptococcal infection, these structures are exposed and become accessible to antibodies. The present study was undertaken, therefore, on the basis of this assumption.
MATERIALS AND METHODS Bacterial strains. Three group A streptococcus strains isolated from patients with duly classified rheumatic fever were used in this study: strains A 5205, type 5; A 5206, type 5; and A 5207, type 18. Another group A streptococcus strain, A 5017, type 49, was isolated during a streptococcal outbreak in a children's home. Several complications were observed during this outbreak: scarlet fever, acute rheumatic fever, purpura, nephritis.
Seven other group A streptococcus strains were used, A 5022, 5038, 5040, 5161, 5163, 5173, and 5177. They were all isolated from carriers. Strains from other streptococcal groups included a group C strain, C 702, and two group D strains, D 1 (Streptococcus faecalis var. faecalis), and D 4 (S. faecalis var. liquefaciens); these were laboratory strains.
Other bacteria also used were a strain of Escherichia coli, a strain of Staphylococcus aureus (both isolated from carriers), and two soil bacilli exhibiting high proteolytic activity, Bacillus megaterium and B. polymixa.
Cultivation. Immediately upon receipt, the strains A 5205, 5206, and 5207 were inoculated into a 60-ml GROUP A STREPTOCOCCUS ON HEART CONNECTIVE TISSUE horse blood, and incubated in a water bath at 37 C for 5 h. The culture, in log phase, was then divided in 1-ml vials which were frozen and maintained at -70 C. These vials were used as inocula for further experiments, so that bacteria underwent a minimal number of subcultures. The virulence of strain A 5017, used for several laboratory purposes, was maintained by continuous passages on mice. Other strains were maintained as laboratory strains.
For the purpose of immunochemical studies, it was necessary to grow bacteria in a medium free of any substance likely to give cross-reactions in the system tested. The following formula was devised for this purpose (in grams per liter of distilled water): phy- BHV. Heart valves from bovine hearts (BHV) were dissected under sterile conditions soon after slaughtering and immediately frozen at -20 C until required. For the experiments, they were thawed, dissected in a sterile environment so as to free them of cardiac muscle, and cut into small pieces of approximately 0.5 cm2.
Extraction of cultures. Bacteria were grown in the phytone-yeast medium for 48 h, in some cases with BHV present and in others with no BHV present (see below). The cultures were decanted and centrifuged, and the supernatant was filtered on membrane filters (Millipore Corp., Bedford, Mass.), pore size 0.45 Mm.
The liquid was cooled to 4 C, and cold trichloracetic acid was added until a final concentration of 2.5% was achieved. The mixture was maintained at 4 C overnight, and then centrifuged. The supernatant was precipitated by 3 volumes of acetone at 4 C for 24 h. The precipitate was recovered by centrifugation and dissolved in water. It is henceforth referred to as the 3 volumes acetone precipitate (3 VAP). The concentration of acetone in the supernatant was raised to 6 volumes to 1, and the mixture was again maintained at 4 C for 24 h. The second precipitate was recovered in the same manner and is referred to as the 6 volumes acetone precipitate (6 VAP). Both acetone precipitates were neutralized to pH 7.0 and extensively dialyzed against distilled water in the cold.
Immunological techniques. Extraction of ureasoluble glycoprotein (USGP) from connective tissue and production of rabbit antisera to USGP (SGP-AS)
have been described in a previous publication (6) . Streptococcal group antisera (whole bacteria) were prepared by the conventional method of Lancefield (14) . Anti group A streptococcus antiserum is abbreviated to ASTR-AS. Antisera to two purified group A streptococcus antigens were also used: an antipolysaccharide antiserum (APS-AS) (7), and an antipeptidoglycan antiserum (APGL-AS) (8 (1).
Qualitative determination of amino acids and amino sugars was performed by thin-layer chromatography on silica gel plates (CCM Merck, Darmstadt, Germany), with benzene-pyridine-n-butanol-water (20:40:50:20, vol/vol) as solvent and ninhydrin for coloration.
RESULTS
Growth of streptococci in phytone-yeast medium. The phytone-yeast medium proved suitable for the growth of group A streptococcus, as compared to Todd-Hewitt broth (Difco) which is generally used for this bacterium. Growth curves in both media were closely parallel. The production of group (C polysaccharide) and type (M protein) antigens, estimated by the capillary precipitation test, was also similar. Other streptococcal strains belonging to groups B, C, D, and G grew equally well in this medium.
Action of bacteria on BHV. Four to 10 g of BHV were added to 250 to 400 ml of phytoneyeast medium, which were then inoculated with the various strains used for the experiments. The 48-h cultures were treated as described in Materials and Methods, and 3 VAP and 6 VAP were tested by immune precipitation in gel with the various antisera.
Controls were made by including in each set of experiments the following: (i) one Cv controls occasionally gave one to three lines of precipitation with SGP-AS (Fig. 1) . 3 VAP and 6 VAP from the strains A 5205 and 5206 contained material immunologically active both with ASTR-AS and SGP-AS. No differences were observed between the two concentrations of acetone, and the subsequent results relate to 6 VAP, which was considered as being more purified. Preparations containing strains A 5205 or 5206 together with BHV were the only ones which reacted with both antisera; the lines of precipitations showed a partial identity reaction between the two immunological systems (Fig. 1) . Trichloracetic acid precipitates showed no immunological activity (Fig. 2) .
Other group A streptococcal strains used in this study, including strain A 5207, did not produce similar results. Although they occasionally showed lines with ASTR-AS or SGP-AS separately, a common precipitating system with partial identity reactions was never observed. Extracts from groups C and D cultures occasionally gave one line with the homologous antistreptococcal antisera, but none were obtained in the other systems. E. coli, S. 
03
aureus, and B. megaterium were negative. B. polymyxa preparations showed a strong precipitation with SGP-AS, but none with ASTR-AS (Fig. 3) . The results of immunoprecipitations are summarized in Table 1 .
Immunological characterization of active 6 VAP. The precipitation line between 6 VAP from active strains and ASTR-AS showed an identity reaction with APS-AS (Fig. 4) . In immunoelectrophoresis, the immunologically active part of 6 VAP moved towards the anode and showed one precipitation line with ASTR-AS and two with AGPL-AS, one of which has an identity reaction with the preceding one (Fig. 5) . Quantitative precipitation curves of ASTR-AS and SGP-AS with group A-purified polysaccharide, urea-soluble peptidoglycan, and active 6 VAP are given in Fig. 6 . These results are supplemented by those relating to quantitative inhibition of the same system (Fig.  7 ). It will be seen that active 6 VAP had in both systems an immunological activity approximately half that of the specific antigen. With ASTR-AS, this activity was totally inhibited by purified group A streptococcus polysaccharide and urea-soluble peptidoglycan. With SPG-AS, the same antigens had only a partial inhibitory activity. active streptococcal strain together with BHV. The sialic acid content is particularly of interest as in this case it is twice that obtained in the case of the controls.
Evidence of streptococcal extracellular products active on BHV. Polycarbonate centrifugation tubes (Sorvall, Norwalk, Conn.) were cut near the bottom. The cut end was polished and obturated by attaching a cellulose acetate membrane, pore size 0.10 um, by means of acetone. The diffusion chamber prepared in this manner was sterilized by autoclaving, filled with small pieces of BHV, closed with the tube screw cap, and dipped in vials containing phytone-yeast medium, which were then inoculated with the same strains as previously. After 3 to 4 days of incubation, the diffusion chamber was removed and the cultures were treated and M \ g g . . . . . . . . . . . . . pm, and added to several grams of BHV. The vial was incubated at 37 C for 48 h in an agitated water-bath. The supernatant was decanted, filtered, and extracted as described. 6 VAP from this preparation showed an immunological reactivity with ASTR-AS and SGP-AS. DISCUSSION Extraction by 6 volumes of acetone of the medium used in this study, after a previous precipitation by trichloracetic acid, gave a product whose composition as to proteins, oses, osamines, uronic acid, and sialic acid, under various conditions of incubation, was determined. When two group A streptococcus strains, isolated from rheumatic patients, were grown in this medium in presence of BHV, certain substance(s) was found in this extract.
Gross analysis of this substance(s), although the results could not be related with certainty to a defined molecule, seems compatible with the composition of a glycoprotein (10, 18) . The negative charge of the immunologically active part of this extract is akin to that of the structural glycoprotein extracted from heart connective tissue by the action of urea (6) . The extract, when prepared from a medium that is not inoculated, shows no immunological activity, either with anti-group A streptococcus antiserum or with antiserum to soluble structural glycoprotein antiserum. On the other hand, it shows various degrees of activity when the medium is previously inoculated with group A streptococci, or some other bacteria, or with bovine heart valves, or both. However, more complete immunological reactivity with both antisera, giving rise to a partial identity reaction, is encountered only when the same strains are grown in the presence of heart valves.
Thus, controls rule out the possibility that GROUP A STREPTOCOCCUS ON HEART CONNECTIVE TISSUE the immunologically active substance(s) is produced by the group A streptococcus in routine conditions of growth. There is a possibility that this substance(s) is induced by the bacteria from precursors discharged in the medium by heart valves. The analysis of the active substance(s) is not in favor of this hypothesis, since its composition (and especially its content in sialic and uronic acids and in neutral oses) is rather different from that of the currently known streptococcal products. Attempts to precipitate the postulated streptococcal "enzyme" with (NH4) 2SO4 tend to bear the hypothesis of a streptococcal product able to extract the immunologically active substance from the connective tissue of the heart valve. This point, obviously very important, should be confirmed. In this case, the data would appear to indicate that the mechanism of rheumatic heart lesions comprises "two stages." First, streptococcal product(s) spreading from the focus of infection appear to expose immunologically active sites in the connective tissue of the heart. These sites may then become accessible to the antibodies to streptococcal polysaccharide elicited by the focal infection. This pathogenesis presupposes an immunological relationship between the structural connective glycoprotein and the streptococcal polysaccharidic antigen. It has been shown that the N-acetyl glucosamine of the latter plays the dominant role as to its specific antigenic properties (15) . Glucosamine is also the common determinant between group A streptotoccal polysaccharide and the soluble structural glycoprotein of the connective tissue (6) . Results relating to the inhibition of the anti-group A streptococcus antiserum/active acetone extract system confirm that N-acetyl glucosamine is the fundamental determinant in this system; this is also confirmed if we recall that urea-soluble peptidoglycan, which has an inhibitory activity similar to that of streptococcal polysaccharide, has been shown to possess a free N-acetyl glucosamine (8) . This hypothesis, however, gives rise to objections which call for further clarification. The presence of a specific enzyme in certain strains of group A streptococci could be the "rheumatogenic factor" which has sometimes been postulated but which has not yet been clearly demonstrated. We were able to show this activity in only two of the four rheumatogenic strains examined. Nor do we know to what extent the production of this enzyme(s) may depend on the degree of virulence of the strain or on a lysogenic state. Furthermore, should the proposed mechanism be at the origin of heart rheumatic lesions, these would take place, at least at the initial stage, in the connective tissue. This opinion has been widely accepted, but was challenged by a recent study which stresses the importance of the muscular cell at the origin of the lesions (17) . Furthermore, the proposed mechanism does not satisfactorily explain the recurrence of the rheumatic heart disease. If a streptococcal hydrolase (glucosidase) is produced by streptococcal rheumatogenic strains, this enzyme might be immunogenic, and it seems difficult to explain why it is not inhibited by antibodies during subsequent periods of infections.
Further studies are thus needed to define the nature of the immunologically active substance extracted from the heart connective tissue by the action of the group A streptococcus and its relationship with the structural glycoproteins of the connective tissue, to characterize the bacterial "enzyme(s)," and to clarify the pathogenic mechanism, which may well involve cellular participation. The results observed should also be applied to human pathology and confirmed by clinical observations. We think, however, that the data presented here suggest a new mode of investigation with respect to a physiopathological problem which yet remains intriguing.
